Euroapi S.A.

Paris Stock Exchange EAPI.PA

Euroapi S.A. Gross Profit for the year ending December 31, 2023: USD 181.68 M

Euroapi S.A. Gross Profit is USD 181.68 M for the year ending December 31, 2023, a -4.01% change year over year. Gross profit is the difference between revenue and the cost of revenue, representing the profit earned from core business operations.

Euroapi S.A. Gross Profit for the year ending December 31, 2022 was USD 189.27 M, a 52.40% change year over year.
Euroapi S.A. Gross Profit for the year ending December 31, 2021 was USD 124.19 M, a 12.34% change year over year.
Euroapi S.A. Gross Profit for the year ending December 31, 2020 was USD 110.55 M, a 12.46% change year over year.
Euroapi S.A. Gross Profit for the year ending December 31, 2019 was USD 98.31 M.

Key data

Date	Gross Profit	Operating Income	EBIT	EBITDA

Paris Stock Exchange: EAPI.PA

Euroapi S.A.

CEO	Mr. Ludwig De Mot
IPO Date	May 6, 2022
Location	France
Headquarters	15 Rue Traversiere
Employees	3,650
Sector	Healthcare
Industries Pharmaceuticals Baby & Childcare Chemicals & Advanced Materials Cleaning Supplies Cosmetics Drugstores & Retail Pharmacies Personal Care Plastics

Description

Euroapi SA develops, manufactures, markets, and distributes active pharmaceutical ingredients and intermediates used in the formulation of medicines for human and veterinary use. The company was incorporated in 2021 and is based in Paris, France.

Key trends

Past 5 years